搜尋結果
CSPC PHARMA's US Clinical Trial Application for Highly Selective MAT2A Inhibitor Approved
AASTOCKS.com· 51 分鐘前AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities ...
Erin Cuthbert: Chelsea's unsung star making a name for herself with Champions League ...
Goal.com· 3 小時前It was not the highly-lauded Lauren James, record-breaking signing Mayra Ramirez or any of the ...
Snowflake releases a flagship generative AI model of its own
TechCrunch· 2 日前All-around, highly generalizable generative AI models were the name of the game once, and they ...
Is ‘Arthur The King’ Streaming? Here Are Ways To Watch Mark Wahlberg’s Dog Movie Online
Forbes· 3 日前Wahlberg stars as the athlete — renamed Michael Light — in the film, which tells the true story ...
How to watch today's Indiana Pacers vs Milwaukee Bucks NBA Game 3: Live stream, TV channel, ...
Goal.com· 18 分鐘前The Indiana Pacers will host the Milwaukee Bucks in a thrilling NBA matchup on April 26, 2024, at 5:30 pm EDT, at Gainbridge ...
Young Post’s sister branch, Posties, wins silver at global media awards
South China Morning Post· 1 日前Following the highly successful revamp of Young Post, which garnered the prestigious gold award ...
Labour Department highly concerned about fatal work accident that happened in Sha Tin last ...
HKSAR Government Press Releases· 3 日前The Labour Department (LD) is highly concerned about a fatal work accident that happened in Sha Tin last ...
Exclusive: ByteDance prefers TikTok shutdown in US if legal options fail, sources say
Reuters· 15 小時前TikTok owner ByteDance would prefer to shut down its loss-making app rather than sell it if the ...
Chinese anime fans treated to visual delight with releases of Japanese movies
China Daily· 4 小時前April has become a visual extravaganza for Chinese anime enthusiasts, with the recent release ...
Red Bull respond to reports Newey wants out
Reuters· 15 小時前Red Bull said Formula One's most sought after designer Adrian Newey was signed up until at ...